By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CeNeRx BioPharma, Inc. 

270 Cornerstone Drive
Suite 103
Cary  North Carolina  27519  U.S.A.
Phone: 866-287-2622 Fax:



Company News
CeNeRx BioPharma, Inc. Completes $4.85 Million Financing 12/9/2011 7:13:16 AM
CeNeRx BioPharma, Inc. Announces FDA IND Approval for its Neuroprotective Agent in Chemotherapy-Induced Neuropathy and Results From First Human Study 2/9/2011 7:53:59 AM
CeNeRx BioPharma, Inc. Initiates Phase II Trial of TriRima(TM) as Monotherapy in Treatment Resistant Depression 1/6/2011 6:39:35 AM
CeNeRx BioPharma, Inc.'s Novel Antidepressant TriRima(TM) Demonstrates Key Safety Benefit in Pivotal Safety Study 11/2/2010 10:55:59 AM
CeNeRx BioPharma, Inc. Completes $13 Million Series C Financing 8/13/2010 7:02:04 AM
New Clinical Study Shows Anxiolytic Potential of CeNeRx BioPharma, Inc.'s Novel Mechanism HPA Axis Modulator Compounds 1/12/2010 2:31:07 PM
Publication in Neuropsychopharmacology Confirms CeNeRx BioPharma, Inc.'s Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 12/7/2009 2:12:13 PM
CeNeRx BioPharma, Inc. Completes $9 Million Financing 6/16/2009 7:24:03 AM
CeNeRx BioPharma, Inc. Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders 6/16/2009 7:22:51 AM
CeNeRx BioPharma, Inc. Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors 4/1/2009 9:07:47 AM